Compare Align Technology, Inc. (ALGN) vs Lam Research Corporation (LRCX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Align Technology, Inc. vs Lam Research Corporation — how do they compare? Align Technology, Inc. trades at $179.9 (market cap $12.86B), while Lam Research Corporation trades at $335.48 (market cap $438.11B). The key difference: Lam Research Corporation is far larger — about 34.1× Align Technology, Inc.'s market cap, and Lam Research Corporation pays a 0.3% dividend while Align Technology, Inc. pays none. Which is the better fit depends on your goals.
| ALGN | LRCX | |
|---|---|---|
Market Cap | $12.86B | $438.11B |
Sector | Health | Technology |
52-Week High | $207.19 | $433.33 |
52-Week Low | $124.88 | $94.84 |
Enterprise Value | $11.92B | $437.10B |
Dividend Yield | — | 0.3% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
Lam Research (LRCX) trades at $350.33, down 0.8% on the day, with a neutral technical signal and bullish moving averages. The stock shows strong fundamentals with revenue growth to $18.44B in 2025 and net income of $5.36B, supported by consistent earnings beats. Recent news highlights AI-driven demand for semiconductor equipment, though valuation ratios like a P/E of 66.22 raise concerns about premium pricing.
Outlook remains positive with a consensus price target of $393, representing 12% upside, driven by AI infrastructure spending. Risks include high valuation sensitivity and semiconductor cycle volatility. Analyst sentiment is strongly bullish with 78% buy ratings, but investors should monitor execution against elevated expectations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Align Technology, Inc.
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →About Lam Research Corporation
Lam Research manufactures equipment used to fabricate semiconductors. The firm is focused on the etching, deposition, and clean markets, which are key steps in the semiconductor manufacturing process, especially for 3D NAND flash storage, advanced DRAM, and leading-edge logic/foundry chipmakers. Lam's flagship Kiyo, Vector, and Sabre products are sold in all major geographies to key customers such as Samsung Electronics, Micron, Intel, and Taiwan Semiconductor Manufacturing.
Read more on LRCX →
